Lovaza Oral Capsule, Liquid Filled 1G Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

Lovaza: Oral capsule, liquid filled (1g)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file DrugItem_18104.JPG
Lovaza 1g Softgel Cap
GlaxoSmithKline Group of Companies
Pill Identification: LOVAZA,REL900 
Drug Image file DrugItem_18104.JPG
Lovaza 1g Softgel Cap
GlaxoSmithKline Group of Companies
Pill Identification: LOVAZA,REL900 

What is this Medicine?

FISH OIL, OMEGA-3 FATTY ACIDS (Fish Oil, oh MAY ga 3 fatty AS ids) are essential fats. It is used to treat high triglyceride levels.

CVS Pharmacy Patient Statistics for Lovaza: Oral capsule, liquid filled(1g)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information
Select a Medication

Lovaza 1g Softgel Capsule

NDC: 001730783
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Hypertriglyceridemia

Storage Information
Protect from freezing
Store at 77 degrees F; excursions permitted to 59-86 degrees F
Lovaza 1g Softgel Capsule
Drug Image file DrugItem_18104.JPG
GlaxoSmithKline Group of Companies
Pill Identification: LOVAZA,REL900 
Shape: capsule,oblong
Color: yellow
Drug Image file DrugItem_11124.JPG
GlaxoSmithKline Group of Companies
Pill Identification: LOVAZA,REL900 
Shape: capsule,oblong
Color: yellow

Reported Side Effects for Lovaza 1g Softgel Capsule

Skin Rash Incidence:
1.8%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
3.0%*
Severity: MILD
Onset: EARLY
Stomach Pain Incidence:
3.0-5.0%*
Severity: MILD
Onset: EARLY
Belching Incidence:
3.0-4.0%*
Severity: MILD
Onset: EARLY
Metallic Taste Incidence:
4.0%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
4.0-6.0%*
Severity: MILD
Onset: EARLY
Loose Stools Incidence:
7.0-15.0%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Lovaza

We want to help you stay educated about the medications you are taking. View other
patient's observations and share your own.

Be sure to consult your health care provider before taking any medications. Other
patient's comments should not be considered medical advice or health care provider
recommendations.